| |
MA |
HA |
| Age (Years) |
20-39 (%) |
40-59 (%) |
> 60 (%) |
20-39 (%) |
40-59 (%) |
> 60 (%) |
| No Pathology |
25 (Smokers) |
|
|
10 (Obese) |
|
|
| Allergy |
50 |
40 |
20 |
27 |
|
|
| Hypertension/Dyslipidemias |
25 |
60 |
80 |
|
|
|
| Fibromatosis/Polyposis |
|
|
|
27 |
50 |
50 |
| Thyroid disease/Autoimmunity |
|
|
|
27 |
30 |
15 |
| Viral Infections |
|
|
|
9 (HPV) |
20 (HCV) |
20 (HCV) |
| Cancer |
|
|
|
|
|
15 |
Percentage (%) refers to the number of affected subjects per each group of PAR-PARP levels. |